Diabetes and other factors may reduce the lifesaving effectiveness of dexamethasone for patients with severe COVID-19, new research suggests.
- About
- Offices
- Initiatives
- Resources
- Give
COVID-19: Dexamethasone Discovery Carries Treatment Implications
Office of the Vice President for Research
Varsity Hall
Box 400301
136 Hospital Drive
Charlottesville, VA 22904
PHONE: 434.924.3606
EMAIL: AskResearch@virginia.edu